secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001493152-24-009220
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 1.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MyMD Pharmaceuticals reincorporates from New Jersey to Delaware
---------------------------------------------------------------

- Merger effective March 4, 2024; no change in company name, business, management, or fiscal year.
- Stockholders approved reincorporation at 2023 annual meeting; common stock retains same CUSIP and symbol MYMD.
- No exchange of stock certificates required; shares automatically convert on a 1:1 basis.
- Rights of stockholders now governed by Delaware General Corporation Law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224009220/0001493152-24-009220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224009220/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-009220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer